These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25993058)

  • 1. Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipids.
    Honda JR; Hess T; Malcolm KC; Ovrutsky AR; Bai X; Irani VR; Dobos KM; Chan ED; Flores SC
    PLoS One; 2015; 10(5):e0126994. PubMed ID: 25993058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontuberculous Mycobacteria Show Differential Infectivity and Use Phospholipids to Antagonize LL-37.
    Honda JR; Hess T; Carlson R; Kandasamy P; Nieto Ramirez LM; Norton GJ; Virdi R; Islam MN; Mehaffy C; Hasan NA; Epperson LE; Hesser D; Alper S; Strong M; Flores SC; Voelker DR; Dobos KM; Chan ED
    Am J Respir Cell Mol Biol; 2020 Mar; 62(3):354-363. PubMed ID: 31545652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products.
    Adhikrao PA; Motiram GM; Kumar G
    Curr Top Med Chem; 2024; 24(15):1291-1326. PubMed ID: 38288807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.
    Rindi L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
    Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
    Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 11. A paucity of knowledge regarding nontuberculous mycobacterial lipids compared to the tubercle bacillus.
    Tran T; Bonham AJ; Chan ED; Honda JR
    Tuberculosis (Edinb); 2019 Mar; 115():96-107. PubMed ID: 30948183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of slowly growing mycobacteria.
    Philley JV; Griffith DE
    Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections.
    Sethiya JP; Sowards MA; Jackson M; North EJ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria.
    Aguilar-Ayala DA; Cnockaert M; André E; Andries K; Gonzalez-Y-Merchand JA; Vandamme P; Palomino JC; Martin A
    J Med Microbiol; 2017 Aug; 66(8):1140-1143. PubMed ID: 28749330
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antimicrobial susceptibility of non-tuberculous mycobacteria.
    Cowman S; Burns K; Benson S; Wilson R; Loebinger MR
    J Infect; 2016 Mar; 72(3):324-31. PubMed ID: 26723913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of antimicrobial resistance in rare mycobacteria from a nosocomial environment.
    Pereira SG; Alarico S; Tiago I; Reis D; Nunes-Costa D; Cardoso O; Maranha A; Empadinhas N
    BMC Microbiol; 2019 Mar; 19(1):62. PubMed ID: 30890149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
    Adjemian J; Olivier KN; Prevots DR
    Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.